steroids - CISMeF

Preferred Label : steroids;

MeSH definition : A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed);

MeSH synonym : Steroid;

MeSH hyponym : catatoxic steroids; Steroids, Catatoxic;

MeSH annotation : GEN; avoid: too general; prefer more specific steroid groups or specific steroids; PLANT STEROIDS see PHYTOSTEROLS is also available.; general or unspecified; prefer specific steroid groups or specific steroids; PLANT STEROIDS see PHYTOSTEROLS is also available;

Wikipedia link : https://en.wikipedia.org/wiki/Steroid;

Is substance : O;

Details

Origin ID

D013256;

UMLS CUI

C0038317;

ATC code(s)
- anabolic steroids [ATC Code]
- corticosteroid derivatives [ATC Code]
- vitamin b-complex with anabolic steroids [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Steroid [ICHI extension code]
- Steroids [PASCAL theme]
- Steroids Given for Kawasaki Disease [NCIt concept]
- Steroids Given for Rheumatic Fever [NCIt concept]
- sterides [Artificial nutrition thesaurus concept]
Currated CISMeF NLP mapping
- Steroid [ICD-11 Extension code]
- Steroid (substance) [SNOMED CT concept]
- Steroid Compound [NCIt concept]
- Steroid hormone [FMA entity]
- Steroid hormone (substance) [SNOMED CT concept]
- Therapeutic Steroid Hormone [NCIt concept]
- steroid hormone, nos [SNOMED Notion]
- steroids [IUPAC Term]
- steroids [MedlinePlus Topic]
Indexing information
- 19-norandrosterone glucuronide [MeSH Supplementary Concept]
- 19-noretiocholanolone glucuronide [MeSH Supplementary Concept]
- 3alpha5betaPC [MeSH Supplementary Concept]
- MSBP1 protein, arabidopsis [MeSH Supplementary Concept]
- hederacolchiside A [MeSH Supplementary Concept]
- hederacolchiside E [MeSH Supplementary Concept]
Record concept(s)
- catatoxic steroids [MeSH concept]
- steroids [MeSH concept]
Related MeSH Supplementary Concept(s)
- (17beta,20R,22E,24R)-1-methyl-19-norergosta-1,3,5,7,9,14,22-heptaene [MeSH Supplementary Concept]
- (17beta,20R,22E,24R)-19-norergosta-1,3,5,7,9,14,22-heptaene [MeSH Supplementary Concept]
- (20S)-5-stigmastene-3beta,7alpha,16beta,20-tetrol [MeSH Supplementary Concept]
- (3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester [MeSH Supplementary Concept]
- (4-(10, 13-dimethyl-3-methylsulfonyloxy-2,3,4,5,6,7,8,9,11,12,14,15,16, 17-tetradecahydro-1H-cyclopenta(a)phenanthren-17-yl)pentyl) methanesulfonate [MeSH Supplementary Concept]
- 11,20,24-trihydroxyecdysone [MeSH Supplementary Concept]
- 11,20,26-trihydroxyecdysone [MeSH Supplementary Concept]
- 11alpha-O-benzoyl-12beta-O-acetyltenacigenin B [MeSH Supplementary Concept]
- 13-ethyl-11-methylenegon-4-en-17-one [MeSH Supplementary Concept]
- 13beta-methyl 19-nor-steroid [MeSH Supplementary Concept]
- 2-deoxy-20-hydroxyecdysone-22-O-glucopyranoside [MeSH Supplementary Concept]
- 22-deoxy-20,21-dihydroxyecdysone [MeSH Supplementary Concept]
- 22-hydroxy-25-furost-5-en-12-on-3beta,22,26-triol 26-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 22alpha,23alpha-epoxy-solanida-1,4,9-trien-3-one [MeSH Supplementary Concept]
- 22alpha,23alpha-epoxy-solanida-1,4-dien-3-one [MeSH Supplementary Concept]
- 23-keto-cladiellin-A [MeSH Supplementary Concept]
- 24beta-ethylcholesta-5, 9(11), 22E-trien-3beta-benzoate [MeSH Supplementary Concept]
- 24beta-methylcholasta-1,8,14,22,25-penten-3-one-5alpha-ol [MeSH Supplementary Concept]
- 24xi-hydroperoxy-24-vinyllathosterol [MeSH Supplementary Concept]
- 25-acetate-nebrosteroid K [MeSH Supplementary Concept]
- 25-epi ritterostatin GN1N [MeSH Supplementary Concept]
- 26,27-dihydroxy-7,24-tirucalladien-3-one [MeSH Supplementary Concept]
- 26-(glucopyranosyloxy)-22-methoxy-furost-5-en-3-yl O-apio-D-furanosyl-1-2-O-(6-deoxymannopyranosyl-1-4)glucopyranoside [MeSH Supplementary Concept]
- 26-O-beta-D-glucopyranosyl-(25R)-5alpha-furostane-12-one-3beta,22alpha,26-triol-3-O-beta-D-glucopyranosyl(1-4)-beta-D-galactopyranoside [MeSH Supplementary Concept]
- 26-O-beta-D-glucopyranosyl-(25S)-5-furost-20(22)-en-12-one-3beta,26-diol-3-O-beta-D-galactopyranosyl-(1-2)-beta-D-glucopyranosyl-(1-4)-beta-D-galactopyranoside [MeSH Supplementary Concept]
- 26-O-beta-D-glucopyranosyl-(25S)-5-furost-20(22)-en-3beta,26-diol-3-O-L-rhamnopyranosyl-(1-2)-(beta-D-glucopyranosyl-(1-4))-beta-D-galactopyranoside [MeSH Supplementary Concept]
- 26-O-beta-D-glucopyranosyl-25(R)-5alpha-furostan-12-one-3beta,22alpha,26-triol-3-O-alpha-L-rhamnopyranosyl-(1-2)-O-(beta-D-glucopyranosyl-(1-4))-beta-D-galactopyranoside [MeSH Supplementary Concept]
- 26-O-beta-D-glucopyranosyl-5alpha-furostan-12-one-20(22)-ene-3beta,23,26-triol-3-O-beta-D-xylopyranosyl-(1-2)-(beta-D-xylopyranosyl-(1-3))-beta-D-glucopyranosyl-(1-4)-(alpha-L-rhamnopyranosyl-(1-2))-beta-D-galactopyranoside [MeSH Supplementary Concept]
- 26-O-beta-D-glucopyranosyl-5alpha-furostan-20(22)-ene-3beta,23,26-triol-3-O-beta-D-xylopyranosyl-(1-2)-(beta-D-xylopyranosyl-(1-3))-beta-D-glucopyranosyl-(1-4)-(alpha-L-rhamnopyranosyl-(1-2))beta-D-galactopyranoside [MeSH Supplementary Concept]
- 26-O-beta-glucopyranosyl-(25S)-5alpha-furostane-12-one-3beta,22alpha,26-triol-3-O-beta-glucopyranosyl(1-4)-(alpha-rhamnopyranosyl(1-2))-beta-galactopyranoside [MeSH Supplementary Concept]
- 26-O-beta-glucopyranosyl-5alpha-furostane-12-one-3beta,22alpha,26-triol-3-O-beta-glucopyranosyl(1-2)-beta-galactopyranoside [MeSH Supplementary Concept]
- 26-O-glucopyranosyl-22-methoxy-furostan-3,26-diol 3-O-(glucopyranosyl-1-2-glucopyranoside) [MeSH Supplementary Concept]
- 26-glucopyranosyloxy-2-methoxy-furost-5-en-3-yl O-apio-furanosyl-1-4-O-(rhamnopyranosyl-1-2)glucopyranoside [MeSH Supplementary Concept]
- 26-hydroxypinnatasterone [MeSH Supplementary Concept]
- 3,3-difluoro-5beta-cholan-24-oic acid [MeSH Supplementary Concept]
- 3,6-dimethyl-2,3,3a,4,5,8,9,10,10,11,11,11-dodecahydro-1H-cyclopenta(a)anthracene-3,8-dione [MeSH Supplementary Concept]
- 3,9beta-hydroxy-22alpha,23alpha-epoxy-9(10)-seco-solanida-1,3,5(10)-triene [MeSH Supplementary Concept]
- 3-(1',2'-ethandiol)-cholest-3beta,5alpha,6alpha,11alpha-tetraol [MeSH Supplementary Concept]
- 3-O-Rha(1-2)(Ara(1-4))Glc-pennogenine [MeSH Supplementary Concept]
- 3-O-beta-D-glucopyranosyl-stigmasta-5,11(12)-diene [MeSH Supplementary Concept]
- 3-O-sulfomarthasterone [MeSH Supplementary Concept]
- 3-hydroxy-22-methoxy-26-O-glucopyranosyloxy-furost-25(27)-en-2-one-3-O-(O-rhamnopyranosyl-(1-2)-O-(O-arabinopyranosyl-(1-2)-O-(xylopyranosyl-(1-3))-glucopyranosyl-(1-4))galactopyranoside) [MeSH Supplementary Concept]
- 3-hydroxy-22-methoxy-26-glucopyranosyloxy-furostan-2-one-3-O-(O-rhamnopyranosyl-(1-2)-O-(O-arabinopyranosyl-(1-2)-O-(xylopyranosyl-(1-3))-glucopyranosyl-(1-4))galactopyranoside) [MeSH Supplementary Concept]
- 3-hydroxy-3,6-dimethyl-2,3,3,4,5,8,9,10,10,11,11,11-dodecahydro-1H-cyclopenta(a)anthracene-8-one [MeSH Supplementary Concept]
- 3-oxo-bisnorchola-1,4-dien-22-oic acid [MeSH Supplementary Concept]
- 3-vanilloyloxy-stigmast-5-ene-7-one [MeSH Supplementary Concept]
- 3beta-dimethylaminocon-5-enin-18-one [MeSH Supplementary Concept]
- 4-acetoxyplakinamine B [MeSH Supplementary Concept]
- 5 alpha-conanin-3 beta-ol [MeSH Supplementary Concept]
- 5,6-dihydro-17-hydroxy icogenin [MeSH Supplementary Concept]
- 5,6-dihydro-glaucogenin C [MeSH Supplementary Concept]
- 6-deoxocastasterone [MeSH Supplementary Concept]
- 6-deoxocathasterone [MeSH Supplementary Concept]
- 6E-hydroximinosteroid [MeSH Supplementary Concept]
- 7,14-epoxyazedarachin B [MeSH Supplementary Concept]
- 7-hydroxy-4,22-stigmastadien-3-one [MeSH Supplementary Concept]
- 9,19-cyclolanosta-24,24-dimethyl-25-en-3-ylhydroxycinnamate [MeSH Supplementary Concept]
- ABBV-3373 [MeSH Supplementary Concept]
- BIOF2 [MeSH Supplementary Concept]
- BTK 8L preparation [MeSH Supplementary Concept]
- CAY-I [MeSH Supplementary Concept]
- CDNC24 steroid [MeSH Supplementary Concept]
- DI-31 compound [MeSH Supplementary Concept]
- E-buxenone [MeSH Supplementary Concept]
- EA-4 (ATRA steroidal analog) [MeSH Supplementary Concept]
- EDP-305 [MeSH Supplementary Concept]
- GW 707 [MeSH Supplementary Concept]
- GW870086X [MeSH Supplementary Concept]
- H 89712 [MeSH Supplementary Concept]
- H89465 [MeSH Supplementary Concept]
- JNJ-1250132 [MeSH Supplementary Concept]
- LALA 87 protocol [MeSH Supplementary Concept]
- LND 796 [MeSH Supplementary Concept]
- MV 8608 [MeSH Supplementary Concept]
- MV 8612 [MeSH Supplementary Concept]
- ORG-34116 [MeSH Supplementary Concept]
- PR-01 steroid [MeSH Supplementary Concept]
- PR-07 steroid [MeSH Supplementary Concept]
- S0597 steroid [MeSH Supplementary Concept]
- SARM42 compound [MeSH Supplementary Concept]
- SN-1 tumacone A [MeSH Supplementary Concept]
- SN-2 tumacone B [MeSH Supplementary Concept]
- SN-3 tumacoside A [MeSH Supplementary Concept]
- SN-4 tumacoside B [MeSH Supplementary Concept]
- SPI-1865 [MeSH Supplementary Concept]
- U 75389G [MeSH Supplementary Concept]
- U 75412E [MeSH Supplementary Concept]
- U 78715G [MeSH Supplementary Concept]
- ZXH951 [MeSH Supplementary Concept]
- acanthifolioside G [MeSH Supplementary Concept]
- amaranzole A [MeSH Supplementary Concept]
- amplexicogenin B-3-O-beta-D-cymaropyranoside [MeSH Supplementary Concept]
- amplexicogenin--3-O-beta-D-cymaropyranosyl-(1-4)-alpha-L-cymaropyranosyl-(1-4)-beta-D-cymaropyranoside [MeSH Supplementary Concept]
- amurensoside A [MeSH Supplementary Concept]
- anemarnoside A [MeSH Supplementary Concept]
- anemarnoside B [MeSH Supplementary Concept]
- antcin A [MeSH Supplementary Concept]
- aphelaketotriol [MeSH Supplementary Concept]
- aphelasteroside C [MeSH Supplementary Concept]
- aragusterol A [MeSH Supplementary Concept]
- aragusterol C [MeSH Supplementary Concept]
- arylmethylaminosteroid 1o [MeSH Supplementary Concept]
- aspafilioside C [MeSH Supplementary Concept]
- athenolide A [MeSH Supplementary Concept]
- atroside [MeSH Supplementary Concept]
- bacosterol-3-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- balanitesin [MeSH Supplementary Concept]
- balanitoside [MeSH Supplementary Concept]
- bebrycoside [MeSH Supplementary Concept]
- beta-anhydroepidigitoxigenin [MeSH Supplementary Concept]
- blazein [MeSH Supplementary Concept]
- buxidin [MeSH Supplementary Concept]
- buxmicrophylline B [MeSH Supplementary Concept]
- buxmicrophylline C [MeSH Supplementary Concept]
- buxmicrophylline D [MeSH Supplementary Concept]
- byssochlamysol [MeSH Supplementary Concept]
- caerulosteroid A [MeSH Supplementary Concept]
- callaphylloside [MeSH Supplementary Concept]
- cambodianoside G [MeSH Supplementary Concept]
- carijodienone [MeSH Supplementary Concept]
- cattienoid B [MeSH Supplementary Concept]
- caudatin [MeSH Supplementary Concept]
- caudatin-3-O-beta-D-cymaropyranosyl-(1-4)-beta-D-cymaropyranosyl-(1-4)-beta-D-cymaropyranoside [MeSH Supplementary Concept]
- caudatin-3-O-beta-D-cymaropyranosyl-(1-4)-beta-D-digitoxopyranoside [MeSH Supplementary Concept]
- caudatin-3-O-beta-D-glucopyranosyl-(1-4)-beta-D-cymaropyranosyl-(1-4)-beta-D-oleandropyranosyl-(1-4)-beta-D-cymaropyranosyl-(1-4)-beta-D-digitoxopyranoside [MeSH Supplementary Concept]
- caudatin-3-O-beta-D-glucopyranosyl-(1-4)-beta-D-oleandropyranosyl-(1-4)-beta-D-cymaropyranosyl-(1-4)-beta-D-digitoxopyranoside [MeSH Supplementary Concept]
- caudatin-3-O-beta-D-oleandropyranosyl-(1-4)-beta-D-cymaropyranoside [MeSH Supplementary Concept]
- ceparoside C [MeSH Supplementary Concept]
- ceparoside D [MeSH Supplementary Concept]
- cephalostatin 10 [MeSH Supplementary Concept]
- cephalostatin 11 [MeSH Supplementary Concept]
- cephalostatin 18 [MeSH Supplementary Concept]
- cephalostatin 19 [MeSH Supplementary Concept]
- cephalostatin 20 [MeSH Supplementary Concept]
- cephalostatin 7 [MeSH Supplementary Concept]
- cephalostatin I [MeSH Supplementary Concept]
- ceragenin CSA-13 [MeSH Supplementary Concept]
- ceragenin CSA-131 [MeSH Supplementary Concept]
- ceragenin CSA-8 [MeSH Supplementary Concept]
- ceragenins [MeSH Supplementary Concept]
- chantriolide A [MeSH Supplementary Concept]
- chantriolide B [MeSH Supplementary Concept]
- chantriolide C [MeSH Supplementary Concept]
- cheiranthoside IX [MeSH Supplementary Concept]
- cheiranthoside VIII [MeSH Supplementary Concept]
- cheiranthoside X [MeSH Supplementary Concept]
- chinenoside II [MeSH Supplementary Concept]
- chinenoside III [MeSH Supplementary Concept]
- chinenoside IV [MeSH Supplementary Concept]
- chinenoside V [MeSH Supplementary Concept]
- cholegenin [MeSH Supplementary Concept]
- cholesta-5,24-diene-3beta,7beta,19-triol [MeSH Supplementary Concept]
- chondrillasterol [MeSH Supplementary Concept]
- chuanbeinone [MeSH Supplementary Concept]
- cinanthrenol A [MeSH Supplementary Concept]
- cladiellin A [MeSH Supplementary Concept]
- clathriol [MeSH Supplementary Concept]
- clerosterol [MeSH Supplementary Concept]
- clerosterol galactoside [MeSH Supplementary Concept]
- clionamine B [MeSH Supplementary Concept]
- clionamine D [MeSH Supplementary Concept]
- convallamaroside [MeSH Supplementary Concept]
- cycloneolitsol [MeSH Supplementary Concept]
- cynatratoside B [MeSH Supplementary Concept]
- degalactotigonin [MeSH Supplementary Concept]
- dendronesterone A [MeSH Supplementary Concept]
- dendronesterone B [MeSH Supplementary Concept]
- dendronesterone C [MeSH Supplementary Concept]
- deoxymiroestrol [MeSH Supplementary Concept]
- dictyophlebine [MeSH Supplementary Concept]
- dihydroplakinamine K [MeSH Supplementary Concept]
- dioscoreside C [MeSH Supplementary Concept]
- dioscoreside D [MeSH Supplementary Concept]
- dioscoreside E [MeSH Supplementary Concept]
- diosgenin-diglucoside [MeSH Supplementary Concept]
- disporoside A [MeSH Supplementary Concept]
- draconin A [MeSH Supplementary Concept]
- draconin B [MeSH Supplementary Concept]
- draconin C [MeSH Supplementary Concept]
- dregeoside D [MeSH Supplementary Concept]
- dregeoside E [MeSH Supplementary Concept]
- dwarkenoic acid [MeSH Supplementary Concept]
- ecdystene [MeSH Supplementary Concept]
- esculeoside C [MeSH Supplementary Concept]
- esculeoside D [MeSH Supplementary Concept]
- flusinolid [MeSH Supplementary Concept]
- fologenin [MeSH Supplementary Concept]
- fortisterol [MeSH Supplementary Concept]
- fragilioside A [MeSH Supplementary Concept]
- fragilioside B [MeSH Supplementary Concept]
- geniculatoside-F [MeSH Supplementary Concept]
- glaucoside H [MeSH Supplementary Concept]
- goniopectenoside B [MeSH Supplementary Concept]
- gordonoside F [MeSH Supplementary Concept]
- gorgostan-5,25-dien-3'-ol [MeSH Supplementary Concept]
- granulatoside A [MeSH Supplementary Concept]
- halityloside D [MeSH Supplementary Concept]
- hecogenin acetate [MeSH Supplementary Concept]
- hemeroside A [MeSH Supplementary Concept]
- hemeroside B [MeSH Supplementary Concept]
- hexanorcucurbitacin F [MeSH Supplementary Concept]
- holadysenterine [MeSH Supplementary Concept]
- hoyagenin [MeSH Supplementary Concept]
- hupehenirine [MeSH Supplementary Concept]
- hupehenizine [MeSH Supplementary Concept]
- hupehenizioiside [MeSH Supplementary Concept]
- icogenin [MeSH Supplementary Concept]
- indioside D [MeSH Supplementary Concept]
- indioside I [MeSH Supplementary Concept]
- isoeruboside B [MeSH Supplementary Concept]
- isonarthogenin 3-O-alpha-L-rhamnopyranosyl-(1-2)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- iyengadione [MeSH Supplementary Concept]
- iyengaroside A [MeSH Supplementary Concept]
- iyengaroside B [MeSH Supplementary Concept]
- japonicoside A [MeSH Supplementary Concept]
- japonicoside B [MeSH Supplementary Concept]
- japonicoside C [MeSH Supplementary Concept]
- junceelloside C [MeSH Supplementary Concept]
- khekadaengoside A [MeSH Supplementary Concept]
- khekadaengoside K [MeSH Supplementary Concept]
- khekadaengoside L [MeSH Supplementary Concept]
- klyflaccisteroid K [MeSH Supplementary Concept]
- klyflaccisteroid L [MeSH Supplementary Concept]
- kochioside A [MeSH Supplementary Concept]
- kochioside B [MeSH Supplementary Concept]
- kochioside C [MeSH Supplementary Concept]
- kurilensoside A [MeSH Supplementary Concept]
- kurilensoside B [MeSH Supplementary Concept]
- kurilensoside C [MeSH Supplementary Concept]
- laschiatrion [MeSH Supplementary Concept]
- leiwansterol A [MeSH Supplementary Concept]
- leiwansterol B [MeSH Supplementary Concept]
- lichuanine [MeSH Supplementary Concept]
- lichuanisinine [MeSH Supplementary Concept]
- linckoside C [MeSH Supplementary Concept]
- linckoside D [MeSH Supplementary Concept]
- linckoside E [MeSH Supplementary Concept]
- lokysterolamine A [MeSH Supplementary Concept]
- lokysterolamine B [MeSH Supplementary Concept]
- luidiaquinoside [MeSH Supplementary Concept]
- luridoside A [MeSH Supplementary Concept]
- luridoside B [MeSH Supplementary Concept]
- lycoperoside F [MeSH Supplementary Concept]
- lycoperoside G [MeSH Supplementary Concept]
- lycoperoside H [MeSH Supplementary Concept]
- macrostemonoside A [MeSH Supplementary Concept]
- macrostemonoside D [MeSH Supplementary Concept]
- macrostemonoside E [MeSH Supplementary Concept]
- macrostemonoside F [MeSH Supplementary Concept]
- malsteroside A [MeSH Supplementary Concept]
- menellsteroid C [MeSH Supplementary Concept]
- methyl protogracillin [MeSH Supplementary Concept]
- methyl spongoate [MeSH Supplementary Concept]
- minutoside A [MeSH Supplementary Concept]
- minutoside B [MeSH Supplementary Concept]
- miroestrol [MeSH Supplementary Concept]
- monanchosterol A [MeSH Supplementary Concept]
- monanchosterol B [MeSH Supplementary Concept]
- myrsigenin [MeSH Supplementary Concept]
- nanjiol A [MeSH Supplementary Concept]
- nanjiol B [MeSH Supplementary Concept]
- nanjiol C [MeSH Supplementary Concept]
- nebrosteroid Q [MeSH Supplementary Concept]
- nebrosteroid R [MeSH Supplementary Concept]
- nebrosteroid S [MeSH Supplementary Concept]
- neocynapanogenin B [MeSH Supplementary Concept]
- neocynaversicoside [MeSH Supplementary Concept]
- neriumogenin-A-digitaloside [MeSH Supplementary Concept]
- nidemin [MeSH Supplementary Concept]
- org 34517 [MeSH Supplementary Concept]
- org 34850 [MeSH Supplementary Concept]
- org 37663 [MeSH Supplementary Concept]
- orthoesterol B [MeSH Supplementary Concept]
- p-chloro-selenosteroid [MeSH Supplementary Concept]
- pachyaximine A [MeSH Supplementary Concept]
- pallidifloside A [MeSH Supplementary Concept]
- pallidifloside B [MeSH Supplementary Concept]
- pallidifloside C [MeSH Supplementary Concept]
- pandaroside F [MeSH Supplementary Concept]
- pandaroside G [MeSH Supplementary Concept]
- pandaroside G methyl ester [MeSH Supplementary Concept]
- paniculatumoside A [MeSH Supplementary Concept]
- parathiosteroid A [MeSH Supplementary Concept]
- parathiosteroid B [MeSH Supplementary Concept]
- parathiosteroid C [MeSH Supplementary Concept]
- paxisterol [MeSH Supplementary Concept]
- pennogenin 3-O-beta-D-xylopyranosyl (1-4)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- pentaceroside A [MeSH Supplementary Concept]
- pentaceroside B [MeSH Supplementary Concept]
- phrygiasterol [MeSH Supplementary Concept]
- physanolide A [MeSH Supplementary Concept]
- pingbeinine [MeSH Supplementary Concept]
- pingbeininoside [MeSH Supplementary Concept]
- plakinamine E [MeSH Supplementary Concept]
- plakinamine F [MeSH Supplementary Concept]
- plakinamine I [MeSH Supplementary Concept]
- plakinamine J [MeSH Supplementary Concept]
- plakinamine K [MeSH Supplementary Concept]
- plakinamine L [MeSH Supplementary Concept]
- plakinamine M [MeSH Supplementary Concept]
- plakinamine N [MeSH Supplementary Concept]
- plakinamine O [MeSH Supplementary Concept]
- polasterol A [MeSH Supplementary Concept]
- polasterol B [MeSH Supplementary Concept]
- polyphyllin II [MeSH Supplementary Concept]
- procesterol [MeSH Supplementary Concept]
- psilasteroside [MeSH Supplementary Concept]
- puqiedine [MeSH Supplementary Concept]
- qinyangshengenin-3-O-beta-D-digitoxopyranoside [MeSH Supplementary Concept]
- rathbunioside R1 [MeSH Supplementary Concept]
- rathbunioside R2 [MeSH Supplementary Concept]
- reineckiagenin A [MeSH Supplementary Concept]
- reineckiagenoside A [MeSH Supplementary Concept]
- reineckiagenoside B [MeSH Supplementary Concept]
- riparoside A [MeSH Supplementary Concept]
- riparoside B [MeSH Supplementary Concept]
- ritterazine A [MeSH Supplementary Concept]
- ritterazine B [MeSH Supplementary Concept]
- ritterazine M [MeSH Supplementary Concept]
- ritterazine N [MeSH Supplementary Concept]
- robeneoside A [MeSH Supplementary Concept]
- robeneoside B [MeSH Supplementary Concept]
- rostratamine-3-O-beta-D-cymaropyranosyl-(1-4)-beta-D-digitoxopyranoside [MeSH Supplementary Concept]
- saracodine [MeSH Supplementary Concept]
- sarcovagine A [MeSH Supplementary Concept]
- schisanlactone A [MeSH Supplementary Concept]
- sinetirucallol [MeSH Supplementary Concept]
- smilaxchinoside A [MeSH Supplementary Concept]
- smilaxchinoside C [MeSH Supplementary Concept]
- sokodoside A [MeSH Supplementary Concept]
- sokodoside B [MeSH Supplementary Concept]
- solanioic acid [MeSH Supplementary Concept]
- solaviaside A [MeSH Supplementary Concept]
- solaviaside B [MeSH Supplementary Concept]
- solaviaside C [MeSH Supplementary Concept]
- spiroakyroside [MeSH Supplementary Concept]
- stauntogenin-3-O-alpha-L-oleandropyranosyl-(1-4)-O-beta-D-digitoxopyranosyl-(1-4)-O-beta-D-oleandropyranoside [MeSH Supplementary Concept]
- stauntoside A [MeSH Supplementary Concept]
- stauntoside B [MeSH Supplementary Concept]
- stigmast-5-ene-3,7,15 -triol [MeSH Supplementary Concept]
- stoloniferone 5 [MeSH Supplementary Concept]
- stoloniferone 6 [MeSH Supplementary Concept]
- stoloniferone E [MeSH Supplementary Concept]
- stoloniferone F [MeSH Supplementary Concept]
- stoloniferone G [MeSH Supplementary Concept]
- suberosol [MeSH Supplementary Concept]
- suberosol B [MeSH Supplementary Concept]
- suchengbeisine [MeSH Supplementary Concept]
- swinhoeisterol A [MeSH Supplementary Concept]
- swinhoeisterol B [MeSH Supplementary Concept]
- taccalonolide A [MeSH Supplementary Concept]
- taccalonolide AF [MeSH Supplementary Concept]
- taccalonolide AI [MeSH Supplementary Concept]
- taccalonolide AJ [MeSH Supplementary Concept]
- taccalonolide E [MeSH Supplementary Concept]
- taccalonolide T [MeSH Supplementary Concept]
- taccaoside C [MeSH Supplementary Concept]
- taccaoside D [MeSH Supplementary Concept]
- tenacigenin B [MeSH Supplementary Concept]
- tenacissimoside A [MeSH Supplementary Concept]
- tenacissoside J [MeSH Supplementary Concept]
- tenacissoside K [MeSH Supplementary Concept]
- tenacissoside L [MeSH Supplementary Concept]
- tenacissoside M [MeSH Supplementary Concept]
- terrestroneoside A [MeSH Supplementary Concept]
- theonellasterone [MeSH Supplementary Concept]
- tigogenin-3-O-beta-D-glucopyranosyl(1-2)-(beta-D-xylopyranosyl(1-3))-beta-D-glucopyranosyl(1-4)-beta-D-galactopyranoside [MeSH Supplementary Concept]
- tigogenin-3-O-beta-D-xylopyranosyl(1-2)-(beta-D-xylopyranosyl(1-3))-beta-D-glucopyranosyl(1-4)-(alpha-L-rhamnopyranosyl(1-2))-beta-D-galactopyranoside [MeSH Supplementary Concept]
- timosaponin AIII [MeSH Supplementary Concept]
- timosaponin B-II [MeSH Supplementary Concept]
- timosaponin E1 [MeSH Supplementary Concept]
- timosaponin E2 [MeSH Supplementary Concept]
- timosaponin F [MeSH Supplementary Concept]
- topsentinol K [MeSH Supplementary Concept]
- topsentinol K trisulfate [MeSH Supplementary Concept]
- topsentinol L [MeSH Supplementary Concept]
- torvaside H [MeSH Supplementary Concept]
- tribufuroside D [MeSH Supplementary Concept]
- trikamsteroside C [MeSH Supplementary Concept]
- trikamsteroside D [MeSH Supplementary Concept]
- trikamsteroside E [MeSH Supplementary Concept]
- triumfettoside [MeSH Supplementary Concept]
- tuberoside [MeSH Supplementary Concept]
- tupichinin A [MeSH Supplementary Concept]
- tylogenin [MeSH Supplementary Concept]
- typaspidoside A [MeSH Supplementary Concept]
- veramadine A [MeSH Supplementary Concept]
- veramadine B [MeSH Supplementary Concept]
- vernoanthelsterone A [MeSH Supplementary Concept]
- vilaprisan [MeSH Supplementary Concept]
- wallichimine A [MeSH Supplementary Concept]
- wallichimine B [MeSH Supplementary Concept]
- withametelin [MeSH Supplementary Concept]
- yayoisaponin B [MeSH Supplementary Concept]
- yayoisaponin C [MeSH Supplementary Concept]
- yibeissine [MeSH Supplementary Concept]
- yonarasterol G [MeSH Supplementary Concept]
- yonarasterol H [MeSH Supplementary Concept]
- yonarasterol I [MeSH Supplementary Concept]
- yuccalan [MeSH Supplementary Concept]
- zingiberenin G [MeSH Supplementary Concept]
See also
- receptors, steroid [MeSH Descriptor]
See also (suggested by CISMeF)
- steroid metabolism, inborn errors [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients